Correlation of antiviral antibodies and morphological changes in bladder cancer patients
- Authors: Kosova I.V1, Loran O.B2, Sinyakova L.A2, Gundorova L.V1, Kosov V.A3, Pogodina I.E4, Kolbasov D.N1
-
Affiliations:
- City Clinical Hospital №68 of the Department of Health of Moscow
- Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
- Komi Republican Oncology Dispensary
- Vologda Regional Clinical Hospital №2
- Issue: Vol 19, No 7 (2017)
- Pages: 28-34
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94820
- ID: 94820
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
I. V Kosova
City Clinical Hospital №68 of the Department of Health of Moscow
Email: kosovainga@mail.ru
канд. мед. наук, врач-уролог урологического отд-ния ГБУЗ ГКБ №68 109263, Russian Federation, Moscow, ul. Shkuleva, d. 4
O. B Loran
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
Email: oleg_loran@gmail.com
акад. РАН, д-р мед. наук, проф. каф. урологии и хирургической андрологии ФГБОУ ДПО РМАНПО 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
L. A Sinyakova
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
Email: l.a.sinyakova@mail.ru
д-р мед. наук, проф. каф. урологии и хирургической андрологии ФГБОУ ДПО РМАНПО 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
L. V Gundorova
City Clinical Hospital №68 of the Department of Health of Moscow
Email: ludovik-213@mail.ru
д-р мед. наук, зав. патологоанатомическим отд-нием ГБУЗ ГКБ №68 109263, Russian Federation, Moscow, ul. Shkuleva, d. 4
V. A Kosov
Komi Republican Oncology Dispensary
Email: zinaidakosova@yandex.ru
врач уролог-онколог, вед. специалист ГУ КРОД 167904, Russian Federation, Syktyvkar, Niuvchimskoe sh., d. 46
I. E Pogodina
Vologda Regional Clinical Hospital №2
Email: utk-irina@yandex.ru
канд. мед. наук, врач-патоморфолог патологоанатомического отд-ния БУЗ ВО ВОКБ №2 162602, Russian Federation, Cherepovets, ul. Danilova, d. 15
D. N Kolbasov
City Clinical Hospital №68 of the Department of Health of Moscow
Email: urology68@rambler.ru
канд. мед. наук, врач-уролог, зав. урологическим отд-нием ГБУЗ ГКБ №68 109263, Russian Federation, Moscow, ul. Shkuleva, d. 4
References
- Клиническая онкоурология. Под ред. Б.П.Матвеева. М.: Вердана, 2003; с. 195-407.
- Harald zur Hausen. Infections causing human cancer. Wiley - VCH Verlag GmbH and Co. KGA, Weinheim, 2006; p. 517.
- Terao S. Shirakawa T, Goda K et al. Recombinant inter; eukin-2 enhanced the antitumor effect of ADV/RSV-HSV-tk/ACV therapy in a murine bladder cancer model. Anticancer Res 2005; 25 (4): 2757-60.
- Sharma P, Callahan M.K, Bono P et al. Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open - label, two - stage, multi - arm, phase 1/2 trial.
- He S, Nakada D, Morrison S.J. Mechanisms of stem cell self - renewal. Annu Rev Cell Dev Biol 2009; 25: 377-406. doi: 10.1146/annurev.cellbio.042308.113248.
- Немцова М.В., Кушлинский Н.Е. Молекулярный патогенез рака мочевого пузыря. Альманах клин. медицины. 2015; 41: 79-88.
- Melnick M, Jaskoll T. CMV-induced embryonic mouse organ of Corti dysplasia: network architecture of dysfunctional lateral inhibition. Birth Defects Res A Clin Mol Teratol 2015; 103 (7): 573-82.
- Michelson S, Alcami J, Kim S.J et al. Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1. J Virol 1994; 68: 5730-7.
- Kwon Y.J, Kim D.J, Kim J.H et al. Human cytomegalovirus (HCMV) infection in osteosarcoma cell line suppresses GM-CSF production by induction of TGF-beta. Microbiol Immunol 2004; 48: 195-9.
- Wan X.X, Yi H, Qu J.Q et al. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non - cancerous nasopharyngeal tissues. Oncol Rep 2015; 34 (5): 2585-601.
- Gulley M.L. Genomic assays for Epstein - Barr virus - positive gastric adenocarcinoma. Exp Mol Med 2015; 47: e134.
- Liang Q, Yao X, Tang S et al. Integrative identification of Epstein-Barr virus - associated mutations and epigenetic alterations in gastric cancer. Gastroenterology 2014; 147 (6): 1350-62.
- Андреева Ю.Ю., Данилова Н.В., Завалишина Л.Э. и др. Опухоли мочевого пузыря. Морфологическая диагностика и генетика. Руководство для врачей. Под ред. Ю.Ю.Андреевой, Г.А.Франка. М.: РМАПО, 2011.
- Epstein J.I, Reuter V.E, Amin M.B. Biopsy interpretation of the bladder. 2-nd Ed. Philadelphia: Lippincott Williams & Wilkins, 2004; p. 271.
- Chow N, Cairns P, Eisenberger C.F et al. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer. Int J Cancer 2000; 89: 514.
- Powles T et al. Inhibition of PD-L1 by MPDL3280A leads to clinical activity in pts with metastatic urothelial bladder cancer (UBC). ASCO Annual Meeting 2014.
- Fukayama M, Hino R, Uozaki H. Epstein-Barr virus and gastric carcinoma: virus - host interactions leading to carcinoma. Cancer Sci 2008; 99 (9): 1726-33.